Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - tadalafil 20 mg - film-coated tablet - 20 mg - tadalafil 20 mg - tadalafil

Canada - English - Health Canada

apotex inc - tadalafil - tablet - 20mg - tadalafil 20mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

apotex inc - tadalafil - tablet - 20mg - tadalafil 20mg - phosphodiesterase type 5 inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: macrogol 8000; croscarmellose sodium; lactose monohydrate; poloxamer; hypromellose; sodium lauryl sulfate; iron oxide yellow; titanium dioxide; hyprolose; microcrystalline cellulose; magnesium stearate - treatment of erectile dysfunction in adult males. this medicine is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium lauryl sulfate; titanium dioxide; iron oxide yellow; croscarmellose sodium; macrogol 8000; hypromellose; hyprolose; poloxamer - treatment of erectile dysfunction in adult males. this medicine is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; hyprolose; macrogol 8000; iron oxide yellow; hypromellose; sodium lauryl sulfate; poloxamer; croscarmellose sodium; iron oxide red; magnesium stearate; titanium dioxide - treatment of erectile dysfunction in adult males. this medicine is not indicated for use by women.

United States - English - NLM (National Library of Medicine)

apotex corp. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies ( 14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology ( 12.2)] . tadalafil tablet

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - tadalafil 5 mg - film-coated tablet - 5 mg - tadalafil 5 mg - tadalafil

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - tadalafil 10 mg - film-coated tablet - 10 mg - tadalafil 10 mg - tadalafil

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - tadalafil -